文献速递先天性心脏病外科

成人先天性心脏病手术风险预测:非手术临床与社会因素占主导

Risk prediction for surgery on adults with congenital heart disease: Nonprocedural clinical and social factors predominate.
PubMed 文献 · J Thorac Cardiovasc Surg · 2025-11-08

该单中心研究分析1995至2024年1109例成人先天性心脏病(ACHD)手术,院内死亡1.4%,20年生存81±3%。PEACH评分判别力良好(AUC 0.78)但高估死亡率(O/E约0.5),非手术因素如感染性心内膜炎、心力衰竭、多次胸骨切开、社会问题等独立预测生存。当前时代(2019-2024)PEACH预测院内死亡AUC 0.79,但主刀医生术前估计的围术期死亡率(POME)判别力最佳。

要点

  • PEACH评分判别力良好但显著高估死亡率,非手术因素占主导。
  • 感染性心内膜炎、心力衰竭、>4次胸骨切开、社会问题等独立预测生存。
  • 当前时代主刀医生术前POME对院内死亡判别力优于PEACH等模型。

核心结论

  • ACHD手术日益复杂,基于手术类型的传统风险模型受限,非手术患者因素强烈预测风险。
  • 个体临床医生的风险预测可优于验证过的风险模型。

研究设计与样本

  • 单中心回顾性队列分析1995至2024年1109例ACHD手术,采用逻辑回归和多相参数模型,变量选择经bootstrap bagging。
  • 亚分析聚焦当前时代2019至2024年311例手术。

主要发现

  • 全队列院内死亡率1.4%(16/1109),约15年出现晚期死亡风险,20年生存率81±3%。
  • PEACH评分AUC 0.78(P<.0001),但高估死亡率(O/E约0.5),且为时间相关生存的独立决定因素(P<.0001)。
  • 其他独立预测因素包括感染性心内膜炎、心力衰竭、>4次既往胸骨切开、社会问题、术前正性肌力药和发绀。
  • 当前时代患者美国心脏协会解剖/生理分级更差、单右心室、心内膜炎、既往胸骨切开、急诊手术、心力衰竭和广泛重建更多(P=.007-.0001),但院内死亡率无差异(1.9%,6/311;P=.41)。
  • 当前时代PEACH预测院内死亡AUC 0.79(P=.04),优于STAT或ACHS;POME判别力最佳。

关键数值与推荐

  • PEACH评分在全队列中AUC 0.78(P<.0001),O/E约0.5。
  • 当前时代PEACH预测院内死亡AUC 0.79(P=.04),POME判别力最佳。

临床怎么用

  • 在ACHD手术风险预测中应重视非手术因素如感染性心内膜炎、心力衰竭、多次胸骨切开和社会问题。
  • PEACH评分可用于风险分层但需注意其高估死亡率,个体化临床判断可能更准确。

局限性

  • 单中心回顾性研究,结果外推需谨慎。
  • PEACH评分高估死亡率,可能影响其校准度。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: STAT categories, the STS-ACHS score, and the Brompton PEACH score have been used for adult congenital heart disease (ACHD) surgical risk prediction. We explored the utility of these risk prediction tools in our 30-year experience, with an emphasis on the most recent 5 years, given the evolving nature of ACHD surgery. METHODS: A total of 1109 ACHD operations performed between 1995 and 2024 at a single institution were analyzed for in-hospital mortality and time-related survival using logistic regression and multiphase parametric modeling, focusing on STAT, ACHS, and PEACH scores, in addition to >400 patient-specific variables. Final variable selection was guided by bootstrap bagging. Subanalyses focused on the current era, 2019 to 2024. RESULTS: In the full cohort (n = 1109), in-hospital mortality was 1.4% (n = 16 of 1109). A late-phase hazard for death emerged at ∼15 years, and 20-year survival was 81 ± 3%. Compared with the PEACH reference cohort, our experience included more revision, Fontan, and heart failure surgeries (including 82 operations related to advanced therapies). Nevertheless, PEACH showed good discrimination (area under the curve [AUC], 0.78; P < .0001) compared to STAT or ACHS, although it significantly overestimated mortality (O/E ∼0.5). PEACH was a strong independent determinant of time-related survival (P < .0001). Other independent predictors included infective endocarditis, heart failure, >4 prior sternotomies, social concerns, preoperative inotropes, and cyanosis. The nature of the surgical procedure did not feature strongly in risk. In the current era (2019-2024; n = 311), patients had worse/more American Heart Association anatomy/physiology grade, single right ventricle, endocarditis, prior sternotomies, urgent surgery, heart failure and extensive surgical reconstructions (all P = .007-.0001), although in-hospital mortality was not different (1.9%; n = 6 of 311; P = .41). PEACH (AUC, 0.79; P = .04) was superior to STAT or ACHS for predicting in-hospital mortality. However, the perioperative mortality estimate (POME) provided by an ACHD surgeon to patients preoperatively provided the best discrimination in the current era. PEACH and POME (P = .0004) predicted time-related survival; other independent predictors-loss to follow-up, infection, heart failure, >4 prior sternotomies, social concerns, inotropes, Fontan physiology, cyanosis, and the nature of surgical procedures-did not predict risk well. CONCLUSIONS: ACHD surgery in quaternary centers is increasingly major revision, endocarditis, and heart failure surgery, hampering conventional risk-prediction models based on procedure. Nonprocedural patient-specific circumstances strongly predict risk; as such, individual clinicians' risk prediction can outperform validated risk models.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Ahmed M, Dolgner S, Ermis P, et al. Risk prediction for surgery on adults with congenital heart disease: Nonprocedural clinical and social factors predominate. J Thorac Cardiovasc Surg. 2025. PMID: 41213468. doi:10.1016/j.jtcvs.2025.10.041

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。